DarioHealth Corp. (DRIO) stock forecast and price target
Price $1.26 · data as of November 13, 2026
12-month price target
Average target$8.20
Upside / downside+550.8%
Analysts5
ConsensusStrong buy
Low $5.00Average $8.20High $12.00
Gold marker: average target · white marker: today’s price ($1.26)
Analyst ratings
Strong buy 0Buy 4Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.46 | +66.4% | $22M |
| Next fiscal year ends December 31, 2027 | $-1.03 | +58.0% | $29M |
| Next quarter ends December 31, 2026 | $-0.41 | +45.8% | $6M |
| Quarter after ends March 31, 2027 | $-0.29 | +69.6% | $6M |
Consensus of the analysts covering DarioHealth, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the DarioHealth stock price target?
The average 12-month target from 5 analysts is $8.20, 550.8% above the current price of $1.26 Targets range from $5.00 to $12.00.
Is DarioHealth a buy according to analysts?
The consensus rating is “Strong buy” (4 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is DarioHealth expected to earn?
Analysts expect EPS of $-2.46 for the fiscal year ending December 31, 2026 and $-1.03 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.